Title : A prospective, open-label trial of galantamine in autistic disorder - Nicolson_2006_J.Child.Adolesc.Psychopharmacol_16_621 |
Author(s) : Nicolson R , Craven-Thuss B , Smith J |
Ref : J Child Adolesc Psychopharmacol , 16 :621 , 2006 |
Abstract :
OBJECTIVE: Post-mortem studies have reported abnormalities of the cholinergic system in autism. The purpose of this study was to assess the use of galantamine, an acetylcholinesterase inhibitor and nicotinic receptor modulator, in the treatment of interfering behaviors in children with autism. |
PubMedSearch : Nicolson_2006_J.Child.Adolesc.Psychopharmacol_16_621 |
PubMedID: 17069550 |
Nicolson R, Craven-Thuss B, Smith J (2006)
A prospective, open-label trial of galantamine in autistic disorder
J Child Adolesc Psychopharmacol
16 :621
Nicolson R, Craven-Thuss B, Smith J (2006)
J Child Adolesc Psychopharmacol
16 :621